Incentives and Anchoring to Improve Long-term HIV Medication Adherence
Official title: INcentives and ReMINDers to Improve Long-term Medication Adherence (INMIND)
Funded at Rand Corporation · NIH-11381019 · Data updated 2026-11-12
A new approach uses habit-based anchoring with daily text reminders and small prizes to help people with HIV stick to their ART routines over time.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rand Corporation NIH-funded |
| Lab location | 1 site (Santa Monica, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $588,124 |
| NIH project number | 5R01MH135751-03 |
| Project ID | NIH-11381019 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults living with HIV who are on ART and open to using daily routines and text-based support to improve adherence.
✕Less likely to help
Individuals not on ART or those unable to participate in daily text messaging or incentive components may not benefit from this approach.
What this research studies
This project supports people living with HIV by pairing ART-taking with an existing daily routine and adding behavioral nudges. It tests whether daily text messages and small monthly incentives help people maintain high ART adherence even after reminders stop. The study builds on earlier pilot work and aims to create a sustainable, easy-to-use strategy that could be adopted in real-world settings. The research is led by RAND Corporation and partners with participants who are managing ART in the context of their everyday lives.
Why it matters
Potential benefit: If successful, patients could experience better viral suppression through easier, more reliable medication routines.
How similar studies have gone: Prior anchoring interventions improved adherence in some groups, and this study extends those methods with real-world text reminders and incentives.
Where this research is happening
-
Rand Corporation
Santa Monica, United States Active
Researchers
- Principal investigator: Linnemayr, Sebastian — Rand Corporation
- Study coordinator: Linnemayr, Sebastian
Related research
Other NIH-funded projects on the same topics.
-
Understanding why patients with blood cancers start and stick with oral cancer medicines
A study to learn what helps or hinders Black patients with blood cancers in starting and continuing their prescribed oral cancer medicines.
-
Incentives and Anchoring to Improve Long-term HIV Medication Adherence
A study tests a simple, daily habit plan combined with friendly reminders and small rewards to help people living with HIV take their ART pills on time.
-
WeCare: a combined mental health and HIV medication support program for high-risk men
A patient-friendly program called WeCare aims to support mental health and improve adherence to HIV meds among high-risk men in settings with limited resources.
-
Medication adherence to epilepsy medicines during pregnancy and related birth outcomes
This project looks at how well pregnant people with epilepsy take their anti-seizure medicines and what happens to their babies.
-
Adaptive mHealth Support to Help Teens with Asthma Stick to Their Inhalers
A multi-site study tests a flexible smartphone-based program to help adolescents with asthma take their inhaled meds more consistently.
-
Reducing High Blood Pressure in Men in Manual Jobs with a Mobile Stress and Medication Adherence Program
A mobile stress-management and medication adherence program aims to help men in manual and trade jobs lower their blood pressure and stay on their prescribed treatment.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.